ArticleIn vivo (Athens, Greece)

Combined OPCML and AXL Expression as a Prognostic Marker and OPCML Enhances AXL Inhibitor in Cholangiocarcinoma.

Ricuphan Khamko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.